NexTechie BioFlux - The Brief: Navigating the Convergence of AI, Biotech, and Shifting Global Regulations

In this edition of BioFlux, we explore "The Great Convergence," a transformative era where the boundaries between biology, medical hardware, and digital intelligence are dissolving. We analyze how evolving regulatory frameworks, including the EU AI Act and new FDA guidances, are redefining industry roadmaps. Key highlights include the competitive expansion of the ADC therapeutic market in China and significant advancements in AI-driven healthcare ecosystems, such as Epic’s clinical automation and Johnson and Johnson’s surgical robotics. This issue provides the strategic depth needed to navigate the shift from experimental AI to scaled, real-world deployment in global healthcare.Subscribe to the paid version of NexTechie BioFlux Newsletter at VIP.NexTechie.IN to gain full access to a Detailed Video and the full Newsletter in English.NexTechie Premium: https://vip.nextechie.inStatutory Declaration: Artificial Intelligence has been utilized within the editorial workflow and in the production of audio and video content, under strict human oversight and comprehensive editorial guidance.